IR Biosciences Holdings Inc.

IRBS · OTC
Analyze with AI
12/31/2010
9/30/2010
6/30/2010
3/31/2010
Assets
Cash & Equivalents$0$0$0$0
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$45$5$19$41
Total Curr. Assets$45$5$19$41
Property Plant & Equip (Net)$21$23$25$27
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$8
Total NC Assets$21$23$25$35
Other Assets$0$0$0$0
Total Assets$66$28$43$76
Liabilities
Payables$0$35$35$1,086
Short-Term Debt$3,638$60$3,044$2,000
Tax Payable$0$3$3$3
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,869$2,308$2,083$324
Total Curr. Liab.$6,507$2,406$5,164$3,413
LT Debt$0$3,104$3,752$4,348
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$6,866$7,599$1,397$4,397
Total NC Liab.$6,866$10,702$5,148$8,745
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$13,373$13,109$10,313$12,158
Equity
Pref Stock$0$0$0$0
Common Stock$17$17$16$14
Retained Earnings-$33,038-$32,695-$29,905-$31,086
AOCI$0$0$0$0
Other Equity$19,714$19,597$19,620$18,990
Total Equity-$13,307-$13,081-$10,269-$12,082
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$66$28$43$76
Net Debt$3,638$3,164$6,795$6,348